Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edwards Lifesciences Corp (NYSE:EW)

107.25
Delayed Data
As of Apr 28
 -1.68 / -1.54%
Today’s Change
61.38
Today|||52-Week Range
112.00
+35.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Operating ActivitiesNet Income / Starting Line123.4M112.7M118.1M140.7M
 
 
 
 
 
Depreciation16.0M16.8M18.5M14.5M
 
 
 
 
 
Total Other Cash Flow2.5M1.5M13.3M2.3M
 
 
 
 
 
Funds From Operations146.0M129.1M146.6M63.6M
 
 
 
 
 
Funds From/For Other Operating Expenses72.7M-41.0M-55.9M-40.2M
 
 
 
 
 
Net Cash Flow - Operating Activities73.3M170.1M202.5M103.8M
 
 
 
 
 
 
InvestingIncrease In Investments-509.0M-255.8M-453.0M-105.3M
 
 
 
 
 
Decrease In Investments349.2M292.1M620.1M181.3M
 
 
 
 
 
Capital Expenditures-20.8M-18.4M-26.0M-37.5M
 
 
 
 
 
Net Assets From Acquisitions 0.00-----11.5M
 
 
Other Investing - Uses0.00-5.1M3.4M1.7M
 
 
 
 
Other Investing - Sources300.0K-300.0K0.00--
 
 
 
Net Cash Flow Investing-180.3M12.5M-175.6M27.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings7.4M5.9M7.4M10.7M
 
 
 
 
 
Long Term Debt Reduction-8.2M-6.5M-4.1M-10.7M
 
 
 
 
 
Net Proceeds Stock Sale23.5M19.0M17.5M27.2M
 
 
 
 
 
Common Preferred Redeemed-101.0M-78.9M-200.0K-100.0M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing9.8M9.9M7.4M14.2M
 
 
 
 
 
Other Uses - Financing3.4M0.004.4M1.1M
 
 
 
 
Net Cash Flow - Financing-71.9M-50.6M23.6M-59.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-17.9M8.6M-2.0M900.0K
 
 
 
 
 
 
Net Change In Cash-178.9M132.0M50.5M71.4M